Skip to main content
NCBI home page
Gut logoLink to Gut
. 1994 Jul;35(7):867–871. doi: 10.1136/gut.35.7.867

Lymphocyte and macrophage interleukin receptors in inflammatory bowel disease: a more selective target for therapy?

M J Weldon 1, J D Maxwell 1
PMCID: PMC1374829  PMID: 8063210

Full text

PDF
867

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bicks R. O., Groshart K. D. The current status of T-lymphocyte apheresis (TLA) treatment of Crohn's disease. J Clin Gastroenterol. 1989 Apr;11(2):136–138. [PubMed] [Google Scholar]
  2. Bistrian B. R., Blackburn G. L., Scrimshaw N. S., Flatt J. P. Cellular immunity in semistarved states in hospitalized adults. Am J Clin Nutr. 1975 Oct;28(10):1148–1155. doi: 10.1093/ajcn/28.10.1148. [DOI] [PubMed] [Google Scholar]
  3. Brynskov J., Freund L., Rasmussen S. N., Lauritsen K., de Muckadell O. S., Williams N., MacDonald A. S., Tanton R., Molina F., Campanini M. C. A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med. 1989 Sep 28;321(13):845–850. doi: 10.1056/NEJM198909283211301. [DOI] [PubMed] [Google Scholar]
  4. Brynskov J., Hansen M. B., Reimert C., Bendtzen K. Inhibitor of interleukin-1 alpha and interleukin-1 beta-induced T-cell activation in serum of patients with active Crohn's disease. Dig Dis Sci. 1991 Jun;36(6):737–742. doi: 10.1007/BF01311230. [DOI] [PubMed] [Google Scholar]
  5. Brynskov J., Tvede N., Andersen C. B., Vilien M. Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut. 1992 Jan;33(1):55–58. doi: 10.1136/gut.33.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brynskov J., Tvede N. Plasma interleukin-2 and a soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Gut. 1990 Jul;31(7):795–799. doi: 10.1136/gut.31.7.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cantarovich D., Le Mauff B., Hourmant M., Peyronnet P., Jacques Y., Boeffard F., Hirn M., Soulillou J. P. Prophylactic use of a monoclonal antibody (33B3.1) directed against interleukin 2 receptor following human renal transplantation. Am J Kidney Dis. 1988 Feb;11(2):101–106. doi: 10.1016/s0272-6386(88)80189-6. [DOI] [PubMed] [Google Scholar]
  8. Cantrell D. A., Smith K. A. The interleukin-2 T-cell system: a new cell growth model. Science. 1984 Jun 22;224(4655):1312–1316. doi: 10.1126/science.6427923. [DOI] [PubMed] [Google Scholar]
  9. Cappello M., Keshav S., Prince C., Jewell D. P., Gordon S. Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation. Gut. 1992 Sep;33(9):1214–1219. doi: 10.1136/gut.33.9.1214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Choy M. Y., Walker-Smith J. A., Williams C. B., MacDonald T. T. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut. 1990 Dec;31(12):1365–1370. doi: 10.1136/gut.31.12.1365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cominelli F., Nast C. C., Clark B. D., Schindler R., Lierena R., Eysselein V. E., Thompson R. C., Dinarello C. A. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest. 1990 Sep;86(3):972–980. doi: 10.1172/JCI114799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Crabtree J. E., Heatley R. V., Juby L. D., Howdle P. D., Losowsky M. S. Serum interleukin-2-receptor in coeliac disease: response to treatment and gluten challenge. Clin Exp Immunol. 1989 Sep;77(3):345–348. [PMC free article] [PubMed] [Google Scholar]
  13. Crabtree J. E., Juby L. D., Heatley R. V., Lobo A. J., Bullimore D. W., Axon A. T. Soluble interleukin-2 receptor in Crohn's disease: relation of serum concentrations to disease activity. Gut. 1990 Sep;31(9):1033–1036. doi: 10.1136/gut.31.9.1033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Crotty B., Hoang P., Dalton H. R., Jewell D. P. Salicylates used in inflammatory bowel disease and colchicine impair interferon-gamma induced HLA-DR expression. Gut. 1992 Jan;33(1):59–64. doi: 10.1136/gut.33.1.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  16. Emmrich J., Seyfarth M., Fleig W. E., Emmrich F. Treatment of inflammatory bowel disease with anti-CD4 monoclonal antibody. Lancet. 1991 Aug 31;338(8766):570–571. doi: 10.1016/0140-6736(91)91133-f. [DOI] [PubMed] [Google Scholar]
  17. Ferguson A. Why study T cell subsets in Crohn's disease? Gut. 1983 Aug;24(8):687–691. doi: 10.1136/gut.24.8.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Fiocchi C., Hilfiker M. L., Youngman K. R., Doerder N. C., Finke J. H. Interleukin 2 activity of human intestinal mucosa mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology. 1984 Apr;86(4):734–742. [PubMed] [Google Scholar]
  19. Haruta J., Kusugami K., Kuroiwa A., Ina K., Shinoda M., Morise K., Iokawa H., Morita M., Ishihara A., Sarai S. Phenotypic and functional analysis of lamina propria mononuclear cells from colonoscopic biopsy specimens in patients with ulcerative colitis. Am J Gastroenterol. 1992 Apr;87(4):448–454. [PubMed] [Google Scholar]
  20. Herrmann F., Cannistra S. A., Lindemann A., Blohm D., Rambaldi A., Mertelsmann R. H., Griffin J. D. Functional consequences of monocyte IL-2 receptor expression. Induction of IL-1 beta secretion by IFN gamma and IL-2. J Immunol. 1989 Jan 1;142(1):139–143. [PubMed] [Google Scholar]
  21. Hess A. D., Colombani P. M. Cyclosporin. Mechanism of action: in vitro studies. Prog Allergy. 1986;38:198–221. [PubMed] [Google Scholar]
  22. Hodgson H. J. Cyclosporin in inflammatory bowel disease. Aliment Pharmacol Ther. 1991 Aug;5(4):343–350. doi: 10.1111/j.1365-2036.1991.tb00037.x. [DOI] [PubMed] [Google Scholar]
  23. Holter W., Goldman C. K., Casabo L., Nelson D. L., Greene W. C., Waldmann T. A. Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes. J Immunol. 1987 May 1;138(9):2917–2922. [PubMed] [Google Scholar]
  24. Honda M., Kitamura K., Takeshita T., Sugamura K., Tokunaga T. Identification of a soluble IL-2 receptor beta-chain from human lymphoid cell line cells. J Immunol. 1990 Dec 15;145(12):4131–4135. [PubMed] [Google Scholar]
  25. James S. P., Kwan W. C., Sneller M. C. T cells in inductive and effector compartments of the intestinal mucosal immune system of nonhuman primates differ in lymphokine mRNA expression, lymphokine utilization, and regulatory function. J Immunol. 1990 Feb 15;144(4):1251–1256. [PubMed] [Google Scholar]
  26. Kroemer G., Wick G. The role of interleukin 2 in autoimmunity. Immunol Today. 1989 Jul;10(7):246–251. doi: 10.1016/0167-5699(89)90262-4. [DOI] [PubMed] [Google Scholar]
  27. Kusugami K., Matsuura T., West G. A., Youngman K. R., Rachmilewitz D., Fiocchi C. Loss of interleukin-2-producing intestinal CD4+ T cells in inflammatory bowel disease. Gastroenterology. 1991 Dec;101(6):1594–1605. doi: 10.1016/0016-5085(91)90397-4. [DOI] [PubMed] [Google Scholar]
  28. Kuziel W. A., Greene W. C. Interleukin-2 and the IL-2 receptor: new insights into structure and function. J Invest Dermatol. 1990 Jun;94(6 Suppl):27S–32S. doi: 10.1111/1523-1747.ep12875017. [DOI] [PubMed] [Google Scholar]
  29. Lichtiger S., Present D. H. Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet. 1990 Jul 7;336(8706):16–19. doi: 10.1016/0140-6736(90)91521-b. [DOI] [PubMed] [Google Scholar]
  30. Ligumsky M., Karmeli F., Sharon P., Zor U., Cohen F., Rachmilewitz D. Enhanced thromboxane A2 and prostacyclin production by cultured rectal mucosa in ulcerative colitis and its inhibition by steroids and sulfasalazine. Gastroenterology. 1981 Sep;81(3):444–449. [PubMed] [Google Scholar]
  31. Lowes J. R., Jewell D. P. The immunology of inflammatory bowel disease. Springer Semin Immunopathol. 1990;12(2-3):251–268. doi: 10.1007/BF00197510. [DOI] [PubMed] [Google Scholar]
  32. MacDonald T. T. The role of activated T lymphocytes in gastrointestinal disease. Clin Exp Allergy. 1990 May;20(3):247–252. doi: 10.1111/j.1365-2222.1990.tb02679.x. [DOI] [PubMed] [Google Scholar]
  33. Mahida Y. R., Gallagher A., Kurlak L., Hawkey C. J. Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol. 1990 Oct;82(1):75–80. doi: 10.1111/j.1365-2249.1990.tb05406.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mahida Y. R., Wu K. C., Jewell D. P. Characterization of antigen-presenting activity of intestinal mononuclear cells isolated from normal and inflammatory bowel disease colon and ileum. Immunology. 1988 Dec;65(4):543–549. [PMC free article] [PubMed] [Google Scholar]
  35. Malkovský M., Loveland B., North M., Asherson G. L., Gao L., Ward P., Fiers W. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature. 1987 Jan 15;325(6101):262–265. doi: 10.1038/325262a0. [DOI] [PubMed] [Google Scholar]
  36. Marx J. Taming rogue immune reactions. Science. 1990 Jul 20;249(4966):246–248. doi: 10.1126/science.2374924. [DOI] [PubMed] [Google Scholar]
  37. Mee A. S., Jewell D. P. Monocytes in inflammatory bowel disease: monocyte and serum lysosomal enzyme activity. Clin Sci (Lond) 1980 Apr;58(4):295–300. doi: 10.1042/cs0580295. [DOI] [PubMed] [Google Scholar]
  38. Meuret G., Bitzi A., Hammer B. Macrophage turnover in Crohn's disease and ulcerative colitis. Gastroenterology. 1978 Mar;74(3):501–503. [PubMed] [Google Scholar]
  39. Miller L. C., Lynch E. A., Isa S., Logan J. W., Dinarello C. A., Steere A. C. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet. 1993 Jan 16;341(8838):146–148. doi: 10.1016/0140-6736(93)90006-3. [DOI] [PubMed] [Google Scholar]
  40. Ming R. H., Atluru D., Spellman C. W., Imir T., Goodwin J. S., Strickland R. G. Peripheral blood mononuclear-cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease. J Clin Immunol. 1987 Jan;7(1):59–63. doi: 10.1007/BF00915426. [DOI] [PubMed] [Google Scholar]
  41. Mueller C., Knoflach P., Zielinski C. C. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology. 1990 Mar;98(3):639–646. [PubMed] [Google Scholar]
  42. Mullin G. E., Lazenby A. J., Harris M. L., Bayless T. M., James S. P. Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology. 1992 May;102(5):1620–1627. doi: 10.1016/0016-5085(92)91722-g. [DOI] [PubMed] [Google Scholar]
  43. Nakamura M., Saito H., Kasanuki J., Tamura Y., Yoshida S. Cytokine production in patients with inflammatory bowel disease. Gut. 1992 Jul;33(7):933–937. doi: 10.1136/gut.33.7.933. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Nicod L. P., el Habre F., Dayer J. M. Natural and recombinant interleukin 1 receptor antagonist does not inhibit human T-cell proliferation induced by mitogens, soluble antigens or allogeneic determinants. Cytokine. 1992 Jan;4(1):29–35. doi: 10.1016/1043-4666(92)90033-n. [DOI] [PubMed] [Google Scholar]
  45. O'Garra A. Interleukins and the immune system 1. Lancet. 1989 Apr 29;1(8644):943–947. [PubMed] [Google Scholar]
  46. Ohashi Y., Takeshita T., Nagata K., Mori S., Sugamura K. Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. J Immunol. 1989 Dec 1;143(11):3548–3555. [PubMed] [Google Scholar]
  47. Pallone F., Fais S., Squarcia O., Biancone L., Pozzilli P., Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut. 1987 Jun;28(6):745–753. doi: 10.1136/gut.28.6.745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Pizzolo G., Vincenzi C., Vinante F., Rigo A., Veneri D., Chilosi M., Dusi S., Poli G., Zambello R., Semenzato G. Highly concentrated urine-purified Tac peptide fails to inhibit IL-2-dependent cell proliferation in vitro. Cell Immunol. 1992 Apr 15;141(1):253–259. doi: 10.1016/0008-8749(92)90144-e. [DOI] [PubMed] [Google Scholar]
  49. Pullman W. E., Doe W. F. IL-2 production by intestinal lamina propria cells in normal inflamed and cancer-bearing colons. Clin Exp Immunol. 1992 Apr;88(1):132–137. doi: 10.1111/j.1365-2249.1992.tb03052.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Raedler A., Fraenkel S., Klose G., Seyfarth K., Thiele H. G. Involvement of the immune system in the pathogenesis of Crohn's disease. Expression of the T9 antigen on peripheral immunocytes correlates with the severity of the disease. Gastroenterology. 1985 Apr;88(4):978–983. doi: 10.1016/s0016-5085(85)80017-2. [DOI] [PubMed] [Google Scholar]
  51. Raedler A., Fraenkel S., Klose G., Thiele H. G. Elevated numbers of peripheral T cells in inflammatory bowel diseases displaying T9 antigen and Fc alpha receptors. Clin Exp Immunol. 1985 Jun;60(3):518–524. [PMC free article] [PubMed] [Google Scholar]
  52. Reed J. C., Abidi A. H., Alpers J. D., Hoover R. G., Robb R. J., Nowell P. C. Effect of cyclosporin A and dexamethasone on interleukin 2 receptor gene expression. J Immunol. 1986 Jul 1;137(1):150–154. [PubMed] [Google Scholar]
  53. Rodgers V. D., Fassett R., Kagnoff M. F. Abnormalities in intestinal mucosal T cells in homosexual populations including those with the lymphadenopathy syndrome and acquired immunodeficiency syndrome. Gastroenterology. 1986 Mar;90(3):552–558. doi: 10.1016/0016-5085(86)91108-x. [DOI] [PubMed] [Google Scholar]
  54. Rubin L. A., Jay G., Nelson D. L. The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol. 1986 Dec 15;137(12):3841–3844. [PubMed] [Google Scholar]
  55. Schreiber S., MacDermott R. P., Raedler A., Pinnau R., Bertovich M. J., Nash G. S. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology. 1991 Oct;101(4):1020–1030. doi: 10.1016/0016-5085(91)90729-5. [DOI] [PubMed] [Google Scholar]
  56. Senju M., Hulstaert F., Lowder J., Jewell D. P. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. Gut. 1991 Jul;32(7):779–783. doi: 10.1136/gut.32.7.779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Senju M., Wu K. C., Mahida Y. R., Jewell D. P. Two-color immunofluorescence and flow cytometric analysis of lamina propria lymphocyte subsets in ulcerative colitis and Crohn's disease. Dig Dis Sci. 1991 Oct;36(10):1453–1458. doi: 10.1007/BF01296815. [DOI] [PubMed] [Google Scholar]
  58. Smith K. A. Interleukin-2: inception, impact, and implications. Science. 1988 May 27;240(4856):1169–1176. doi: 10.1126/science.3131876. [DOI] [PubMed] [Google Scholar]
  59. Solinger A. M., Hess E. V. HIV and arthritis. J Rheumatol. 1990 Apr;17(4):562–562. [PubMed] [Google Scholar]
  60. Symons J. A., Wood N. C., Di Giovine F. S., Duff G. W. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol. 1988 Oct 15;141(8):2612–2618. [PubMed] [Google Scholar]
  61. Toossi Z., Sedor J. R., Lapurga J. P., Ondash R. J., Ellner J. J. Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J Clin Invest. 1990 Jun;85(6):1777–1784. doi: 10.1172/JCI114635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Tvede N., Brynskov J. Interleukin-2 stimulation of blood mononuclear cells from patients with inflammatory bowel disease. APMIS. 1991 Aug;99(8):759–764. doi: 10.1111/j.1699-0463.1991.tb01256.x. [DOI] [PubMed] [Google Scholar]
  63. Waldmann T. A. The multi-subunit interleukin-2 receptor. Annu Rev Biochem. 1989;58:875–911. doi: 10.1146/annurev.bi.58.070189.004303. [DOI] [PubMed] [Google Scholar]
  64. Williams J. G., Hughes L. E., Hallett M. B. Toxic oxygen metabolite production by circulating phagocytic cells in inflammatory bowel disease. Gut. 1990 Feb;31(2):187–193. doi: 10.1136/gut.31.2.187. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES